Clinical trial
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic…
NCT00198991 · Goethe University, Other · Completed
Key facts
| NCT number | NCT00198991 |
|---|---|
| Title | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) |
| Official title | German Multicenter Study for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years (Amend 3) (GMALL 07/2003) |
| Lead sponsor | Goethe University, Other |
| Collaborators | Deutsche Krebshilfe e.V., Bonn (Germany) German Federal Ministry of Education and Research |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphocytic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, Dexamethasone, Vincristine, Daunorubicin, Asparaginase, Methotrexate, Cytarabine, Mercaptopurine, G-CSF, Vindesine and 11 more |
| Enrollment | 1,883 |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 30, 2011 |
| Completion | Jun 30, 2013 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 18, 2022 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: